{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:08:18Z","timestamp":1792516098935,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Familial Partial Lipodystrophy (FPLD) is a disease with wide clinical and genetic variation, with seven different subtypes described. Until genetic testing becomes feasible in clinical practice, non-invasive tools are used to evaluate body composition in lipodystrophic patients. This study aimed to analyze the different anthropometric parameters used for screening and diagnosis of FPLD, such as thigh skinfold thickness (TS), K\u00f6b index (K\u00f6bi), leg fat percentage (LFP), fat mass ratio (FMR) and leg-to-total fat mass ratio in grams (LTR), by dual-energy X-ray absorptiometry, focusing on determining cutoff points for TS and LFP within a Brazilian population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-seven patients with FPLD and seventy-four healthy controls matched for body mass index, sex and age were studied. Data were collected through medical record review after signing informed consent. All participants had body fat distribution evaluated by skinfolds and DXA measures. Fasting blood samples were collected to evaluate glycemic and lipid profiles. Genetic studies were carried out on all patients. Two groups were categorized based on genetic testing and\/or anthropometric characteristics: FPLD+ (positive genetic test) and FPLD1 (negative genetic testing, but positive clinical\/anthropometric criteria for FPLD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighteen (48.6%) patients were classified as FPLD+, and 19 (51.4%) as FPLD1. Unlike what is described in the literature, the <jats:italic>LMNA<\/jats:italic> variant in codon 582 was the most common. Among the main diagnostic parameters of FPLD, a statistical difference was observed between the groups for, K\u00f6bi, TS, LFP, FMR, and LTR. A cutoff point of 20\u00a0mm for TS in FPLD women was found, which is lower than the value classically described in the literature for the diagnosis of FPLD. Additionally, an LFP\u2009&lt;\u200929.6% appears to be a useful tool to aid in the diagnosis of these women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Combining anthropometric measurements to assess body fat distribution can lead to a more accurate diagnosis of FPLD. This study suggests new cutoff points for thigh skinfold and leg fat percentage in women with suspected FPLD in Brazil. Further studies are needed to confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-024-01413-w","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T02:02:12Z","timestamp":1725415332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-3737","authenticated-orcid":false,"given":"Victor Rezende","family":"Veras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-4269","authenticated-orcid":false,"given":"Grayce Ellen","family":"da Cruz Paiva Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-4221","authenticated-orcid":false,"given":"Ivana","family":"da Ponte Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-6551","authenticated-orcid":false,"given":"Virginia Oliveira","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-858X","authenticated-orcid":false,"given":"Fabia Karine","family":"de Moura Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-6910","authenticated-orcid":false,"given":"Camila Lopes","family":"do Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-5612","authenticated-orcid":false,"given":"Maria Helane Gurgel","family":"Castelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-5189","authenticated-orcid":false,"given":"Larissa Luna","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5418-022X","authenticated-orcid":false,"given":"Jessica Silveira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-1735","authenticated-orcid":false,"given":"Cynthia Melissa","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-8726","authenticated-orcid":false,"given":"Renan Magalh\u00e3es","family":"Montenegro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"6","key":"1413_CR1","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","volume":"26","author":"KL Herbst","year":"2003","unstructured":"Herbst KL, Tannock LR, Deeb SS, Purnell JQ, Brunzell JD, Chait A. Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care. 2003;26(6):1819\u201324.","journal-title":"Diabetes Care"},{"key":"1413_CR2","doi-asserted-by":"crossref","unstructured":"Vantyghem MC, Balavoine AS, Douillard C, Defrance F, Dieudonne L, Mouton F, et al. How to diagnose a lipodystrophy syndrome. Annales D\u2019endocrinologie. Elsevier; 2012. pp. 170\u201389.","DOI":"10.1016\/j.ando.2012.04.010"},{"issue":"12","key":"1413_CR3","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101(12):4500\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"1413_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","volume":"54","author":"C Guill\u00edn-Amarelle","year":"2016","unstructured":"Guill\u00edn-Amarelle C, S\u00e1nchez-Iglesias S, Castro-Pais A, Rodriguez-Ca\u00f1ete L, Ord\u00f3\u00f1ez-May\u00e1n L, Pazos M, et al. Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome. Endocrine. 2016;54:411\u201321.","journal-title":"Endocrine"},{"issue":"1","key":"1413_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","volume":"19","author":"Y Handelsman","year":"2013","unstructured":"Handelsman Y, Oral E, Bloomgarden Z, Brown R, Chan J, Einhorn D, et al. The clinical approach to the detection of lipodystrophy\u2013an AACE consensus statement. Endocr Pract. 2013;19(1):107\u201316.","journal-title":"Endocr Pract"},{"issue":"2","key":"1413_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","volume":"108","author":"A Garg","year":"2000","unstructured":"Garg A, Lipodystrophies. Am J Med. 2000;108(2):143\u201352.","journal-title":"Am J Med"},{"issue":"4","key":"1413_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","volume":"20","author":"V Simha","year":"2009","unstructured":"Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol. 2009;20(4):300\u20138.","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"1413_CR8","first-page":"3431","volume":"85","author":"RA Hegele","year":"2000","unstructured":"Hegele RA, Cao H, Anderson CM, Hramiak IM. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab. 2000;85(9):3431\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1413_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/19491034.2018.1454167","volume":"9","author":"C Guill\u00edn-Amarelle","year":"2018","unstructured":"Guill\u00edn-Amarelle C, Fern\u00e1ndez-Pombo A, S\u00e1nchez-Iglesias S, Ara\u00fajo-Vilar D. Lipodystrophic laminopathies: diagnostic clues. Nucleus. 2018;9(1):277\u201388.","journal-title":"Nucleus"},{"issue":"7","key":"1413_CR10","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1210\/clinem\/dgaa137","volume":"105","author":"C Vasandani","year":"2020","unstructured":"Vasandani C, Li X, Sekizkardes H, Adams-Huet B, Brown RJ, Garg A. Diagnostic value of anthropometric measurements for familial partial lipodystrophy, Dunnigan variety. J Clin Endocrinol Metab. 2020;105(7):2132\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"1413_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-4-40","volume":"4","author":"CM Valerio","year":"2012","unstructured":"Valerio CM, Zajdenverg L, de Oliveira JEP, Mory PB, Moyses R, Godoy-Matos AF. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012;4:1\u20136.","journal-title":"Diabetol Metab Syndr"},{"key":"1413_CR12","doi-asserted-by":"crossref","unstructured":"Montenegro RM, Costa-Riquetto AD, Fernandes VO, Montenegro APDR, de Santana LS, de Jorge AA. L, Homozygous and heterozygous nuclear lamin a p. R582C mutation: different lipodystrophic phenotypes in the same kindred. Front Endocrinol (Lausanne). 2018;9(AUG).","DOI":"10.3389\/fendo.2018.00458"},{"issue":"4","key":"1413_CR13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1210\/jc.2009-1293","volume":"95","author":"M Boschmann","year":"2010","unstructured":"Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, Gorzelniak K, et al. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab. 2010;95(4):1634\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"November 2011","key":"1413_CR14","first-page":"3313","volume":"96","author":"A Garg","year":"2015","unstructured":"Garg A, Lipodystrophies. Genetic Acquir Body Fat. 2015;96(November 2011):3313\u201325.","journal-title":"Genetic Acquir Body Fat"},{"issue":"4","key":"1413_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.diabet.2018.09.006","volume":"45","author":"M Kwapich","year":"2019","unstructured":"Kwapich M, Lacroix D, Espiard S, Ninni S, Brigadeau F, Kouakam C, et al. Cardiometabolic assessment of lamin A\/C gene mutation carriers: a phenotype\u2013genotype correlation. Diabetes Metab. 2019;45(4):382\u20139.","journal-title":"Diabetes Metab"},{"issue":"1","key":"1413_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-02091-x","volume":"17","author":"H Mosbah","year":"2022","unstructured":"Mosbah H, Donadille B, Vatier C, Janmaat S, Atlan M, Badens C, et al. Dunnigan lipodystrophy syndrome: French national diagnosis and care protocol (PNDS; Protocole National De Diagnostic et de soins). Orphanet J Rare Dis. 2022;17(1):1\u201323.","journal-title":"Orphanet J Rare Dis"},{"key":"1413_CR17","doi-asserted-by":"crossref","unstructured":"Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of lipids. 2009;1791(6):507\u201313.","DOI":"10.1016\/j.bbalip.2008.12.014"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01413-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T02:02:32Z","timestamp":1725415352000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01413-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01413-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Brazilian Ethics System (Plataforma Brasil: ), with the Certificate of Presentation for Ethical Assessment (CAAE) number: 41766820.2.0000.5045 and opinion number: 4.500.872.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}